GPX4 and Sepsis: The first is the issue of biomarker recognition, which currently lacks validated sepsis-induced ALI/ARDS-specific ferroptosis biomarkers, and GPX4 activity in plasma acylcarnitine and BAL fluid cells is a promising candidate (64, 65).